People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...

Taryn Robertson, a professor at Randolph College, is currently fundraising and training to run a marathon for her father who ...

Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

Marc Cohn, a Cleveland native and a Grammy Award-winning singer best known for his hit "Walking in Memphis," revealed he was ...

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...

New report from The National Alliance for Caregiving, in partnership with The Michael J. Fox Foundation and Arcadia University , examines complexities of Parkinson's caregiving ...

A Swindon man with Parkinson's disease will skydive from 15,000 feet to raise awareness and funds for charity.

Nicole LaBolle noticed a tremor in her arm in her '20s but blamed it on drinking too much coffee and a lack of sleep ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...